Apimeds Pharmaceuticals US Reports Third Quarter 2026 Results, Delivers First Operating Revenue from Technology Services
Quarterly revenue of $2.89 million and operating income of $2.0 million as the company completes its
Quarterly revenue of $2.89 million and operating income of $2.0 million as the company completes its